NewsBenzingaRBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295 RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295 Benzinga 2026.11.06 18:10 (GMT+0) Open on Benzinga Other news How Tokenized Nvidia Traded Through Two Weeks of Huang Headlines What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66